GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select l ...
Penumbra Inc. announced it has received CE Mark approval for its Red 72 Silver Label and Red 72 Silver Label with SendIt technolog ...
Nectero Therapeutics announced the 2-year findings from a first-in-human (FIH) multicenter study evaluating treatment of small- to ...
Artivion, Inc. announced that the FDA has approved the company’s AMDS hybrid prosthesis, an aortic arch remodeling device fo ...
Johnson & Johnson announced the initiation of its SKYWARD investigational device exemption (IDE) clinical program evaluating t ...
CereVasc, Inc. announced it has completed patient enrollment in the STRIDE pivotal trial, which is evaluating the company’s ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
LeMaitre Vascular, Inc. Glow 'N Tell 55-cm Tape 55 Centimeter markings on flexible radiopaque ruler LeMaitre Vascular, Inc. Glow 'N Tell Tape 30 Centimeter markings on flexible radiopaque ruler ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results